Discusses AD at a molecular level, from the misfolding and aggregation of amyloid-beta and tau proteins to disruptions in cellular homeostasis, mitochondrial dysfunction, and neuroinflammation. Presents new therapeutics for neurodegenerative disorders, behavioral intervention.